Complete genome sequences of sp., sp., sp., sp., sp., and sp. strains from human clinical infections collected at diagnostic units in 2020.

Members of and phyla are frequently considered bacterial infectious agents in humans. As part of a large sequencing project of clinically relevant pathogens, we hybrid-assembled complete genomes of , , , , and species isolated from clinical specimens.

Whole genomes from bacteria collected at diagnostic units around the world 2020.

The Two Weeks in the World research project has resulted in a dataset of 3087 clinically relevant bacterial genomes with pertaining metadata, collected from 59 diagnostic units in 35 countries around the world during 2020. A relational database is available with metadata and summary data from selected bioinformatic analysis, such as species prediction and identification of acquired resistance genes.

Prevalence of extended spectrum Beta-Lactamase producing species from patients' specimens in a tertiary teaching hospital in Ile-Ife, Southwest Nigeria.

Objective: This study determined the prevalence of ESBL genes amongst species isolated from patients' specimens attending a Tertiary Teaching Hospital, in Ile-Ife, Southwest Nigeria.

Methods: A cross sectional study of presumptive isolates of (n=180) were collected, after ethical approval in the microbiology laboratory. Isolates were identified to species level by conventional biochemical tests and MicrobactTM 24E Identification Kits.

Antibiotic resistance pattern of spp. from patients in a tertiary hospital in South-West Nigeria.

Introduction: Pseudomonads constitute critical agents of opportunistic infections in hospital settings particularly in immunocompromised patients and is a major flagship member of these infectious agents. This study assessed the distribution of spp. associated with infections in patients and their antibiotic resistance patterns as part of an antibiotic stewardship intervention program and resistance surveillance.

Extended-spectrum Beta-lactamase Orthopedic Wound Infections in Nigeria.

Background: Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria are emerging and impacting significantly on the management of patients and hospital costs. Besides, they are not being routinely sought after in diagnostic laboratories thus contributing to treatment failure.

Materials And Methods: Bacterial isolates from wounds of 45 patients were identified using commercial identification kits and antibiotic susceptibility was evaluated by the Bauer-Kirby method.

Invasive bacteria isolates from children with severe infections in a Nigerian hospital.

Background: Little information is available about the aetiology and epidemiology of serious bacterial infections in Nigeria. This study determined bacterial isolates from blood and cerebrospinal fluid (CSF) of children presenting in the emergency room of a teaching hospital in Nigeria.

Method: From October 2005 to December 2006, children aged two to 60 months presenting with signs of acute systemic infections were recruited.

Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?

Mycobacterium bovis is best identified by screening those isolates of the Mycobacterium tuberculosis complex that have any pyrazinamide (PZA) resistance, using a confirmatory test such as spoligotyping, biochemical testing, or genomic deletion analysis. The sensitivity for detection of M. bovis is lowered to 82% when only PZA-monoresistant isolates are screened.

Genomic analysis distinguishes Mycobacterium africanum.

Mycobacterium africanum is thought to comprise a unique species within the Mycobacterium tuberculosis complex. M. africanum has traditionally been identified by phenotypic criteria, occupying an intermediate position between M.